PROBIOTIC STRAIN BIFIDOBACTERIUM BREVE MV-16, PRODUCING LACTIC ACID, APPLICATION OF THE STRAIN FOR PREPARING A NUTRIENT COMPOSITION FOR TREATMENT OR PREVENTION OF PULMONARY FOOD DISEASE, NUTRITION

摘要

1. The use of the probiotic strain Bifidobacterium breve MV-16, which has a significant positive effect on the narrowing of the airways, determined by measuring the value of the increased pause (PenH) in the test animals, to prepare a nutritional composition for the treatment or prevention of pulmonary dysfunction selected from the group consisting of from chronic obstructive pulmonary disease (COPD), aspiration, pulmonary dysfunction caused by nonspecific inhaled irritants, pulmonary edema, and tracheal stenosis in a subject. ! 2. The use according to claim 1, wherein said pulmonary dysfunction is selected from the group consisting of chronic obstructive pulmonary disease (COPD), non-allergic asthma, cystic fibrosis, aspiration, endobronchial tumors, endotracheal tumors, pulmonary dysfunction caused by nonspecific inhaled irritants, pulmonary edema , tracheal stenosis and vocal cord dysfunction, and wherein said composition further comprises at least one of the bacteria having anti-inflammatory properties. ! 3. The use according to claim 1 or 2, wherein said composition further comprises one or more carriers and / or proteins, and / or hydrocarbons, and / or lipids, and / or antioxidants, and is in liquid, powder, solid or encapsulated form . ! 4. The use according to claim 1 or 2, wherein said composition is used in an effective amount, wherein said effective amount is from about 1 × 106 to 1 × 1012 colony forming units, preferably from about 1 × 107 to 1 × 1011 colony forming units, more preferably from about 1 × 108 to 5 × 1010 colony